| Document |
Document Title |
|
WO/2013/145289A1 |
Provided is a lysophospholipid-containing cleaning agent that easily destroys cellular membranes such as of red blood cells in the blood and has an excellent cleaning effect on blood stains. This lysophospholipid-containing cleaning agen...
|
|
WO/2013/122064A1 |
Provided is a new, genetically-modifiable strain of green sulfur bacteria that synthesize bacteriochlorophyll e. Specifically provided are: isolated green sulfur bacteria of Chlorobaculum limnaeum strain RK-j-1, represented by accession ...
|
|
WO/2013/123198A2 |
A method of forming structures utilizing a hydrated lime material. A hydrated lime material is formed that is impermeable to water that is formed by subjecting a quicklime to a mixer and adding a surfactant and water to form the hydrated...
|
|
WO/2013/109865A2 |
The invention provides non-naturally occurring microbial organisms having a (2- hydroxy-3-methyl-4-oxobutoxy) phosphonate (2H3M40P) pathway, p-toluate pathway, and/or terephthalate pathway. The invention additionally provides methods of ...
|
|
WO/2013/025868A2 |
New semiconductor nanoparticles and manufacturing technologies, including novel methods, systems, and compositions, are provided herein. Robust, reproducible production of large amounts of semiconductor nanoparticles, such as quantum dot...
|
|
WO/2012/135591A2 |
The present invention provides methods for a robust production of isoprenoids utilizing the DXP biosynthetic pathway. The invention also provides nucleic acids, enzymes, expression vectors, and genetically modified host cells for carryin...
|
|
WO/2012/078852A2 |
A method of fractionating biomass, by permeability conditioning biomass suspended in a pH adjusted solution of at least one water-based polar solvent to form a conditioned biomass, intimately contacting the pH adjusted solution with at l...
|
|
WO/2012/008298A1 |
The present invention relates to: an isoprene oligomer composed of a trans structural moiety represented by formula (1) and a cis structural moiety, wherein at least one of atoms or groups of atoms contained in the trans structural moiet...
|
|
WO/2011/056183A1 |
The invention described herein presents compositions and methods for a multistep biological and chemical process for the capture and conversion of carbon dioxide and/or other forms of inorganic carbon into organic chemicals including bio...
|
|
WO/2011/033961A1 |
Phospholipase A1 can be produced industrially from a clone having a gene sequence encoding phospholipase A1. Phospholipase A1 is produced industrially by identifying the amino acid sequence for phospholipase A1 derived from Moritella sp....
|
|
WO/2011/021580A1 |
Disclosed are: a novel A-87774 compound having a herbicidal activity or a plant growth regulating activity, or a salt thereof; a microorganism which produces the A-87774 compound or a salt thereof; a method for producing the A-87774 comp...
|
|
WO/2011/009132A2 |
Provided herein are methods and compositions relating to the synthesis of isoprenoid diphosphates using a mutated isopentenyl phosphate kinase.
|
|
WO/2011/004794A1 |
Provided is a method for producing a phospholipid at a low cost by reusing phospholipase A2 in a method for producing the phospholipid whereby an arbitrary fatty acid is bonded to the 2-position of a phospholipid using an esterification ...
|
|
WO/2010/141452A1 |
Provided herein are methods of generating genetically modified yeast cells, e.g., genetically modified diploid and haploid yeast cells, that comprise novel polypeptides, and genetically modified yeast cells that persistently produce isop...
|
|
WO/2010/030091A2 |
The present invention relates to a method for producing biological heme iron through microorganism cultivation, and to an iron supplementing composition containing the heme iron produced by same. The present invention provides a method f...
|
|
WO/2009/138238A9 |
A process for preparing phosphatidylserine comprises reacting a phospholipid with serine in the presence of water, a phospholipase D from carrot and at least one surfactant. A process for preparing phosphatide acid comprises hydrolysing ...
|
|
WO/2008/154731A1 |
Disclosure herein are methods of preparing cross-linked silicone polymers by contacting a silicone polymer and optionally a cross-linking agent with a hydrolytic enzyme under conditions for the cross-linking of the silicone polymer, wher...
|
|
WO/2008/149542A1 |
Disclosed is a method for producing a DHA phospholipid comprising an ω3 unsaturated fatty acid, particularly DHA, as a constituent lipid by using a microorganism in a simpler manner. Specifically disclosed is a method for producing a ph...
|
|
WO/2008/053484A2 |
Described are heavy-metal containing nano-liposome particles, and their use in the treatment of immune-related disorders such as cancer and inflammatory conditions, metal-deficiency-related diseases, and for medical diagnostics. Methods ...
|
|
WO/2007/093523A1 |
The invention relates to a method for the microbial degradation of organo-silicon compounds, silanes or siloxanes. Said method is characterised in that a microorganism strain of the genus Paracoccus is cultivated under anaerobic conditio...
|
|
WO/2007/091731A1 |
The present invention relates to a method for producing a phospholipid containing a long-chain polyunsaturated fatty acid as a constituent (LCPUFA-PL), which comprises: (i) culturing a microorganism belonging to Mortierella sp. under con...
|
|
WO/2007/089038A1 |
A modified phospholipase D having an ability to synthesize phosphatidylinositol which contains: (A) an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO:2 by substitution of at least one of the amino acid ...
|
|
WO/2007/063886A1 |
Disclosed is a method for producing a phospholipid containing a polyvalent unsaturated fatty acid in a two-phase system, wherein the yield of the produced phospholipid is high, isolation of the product is easy, and oxidation of the polyv...
|
|
WO/2007/010892A1 |
[PROBLEMS] To provide a novel phospholipase B (PLB) having a poor hydrolytic activity on phosphatidylinositol (PI) among diacyl-phospholipids, and to provide a process for producing PI and glycerylphosphorylcholine (GPC) from a phospholi...
|
|
WO/2006/136521A1 |
A process is described for the preparation of escitalopram and the pharmaceutically acceptable salts thereof starting from 5-cyanophthalide by a process which provides an enantioselective enzymatic deacylation reaction of a complex of th...
|
|
WO/2006/128639A2 |
Process for the preparation of phosphatidylserine of formula CH2OR1 CHOR2 CH2O-P(=O)-OCH2-CH(NH2)-COOH X wherein R1 and R2 independently represent a saturated, mono-unsaturated or polyunsaturated acyl C10-C30, X=OH or OM where M=alkaline...
|
|
WO/2006/126334A1 |
It is intended to provide a novel supply source of phospholipase A1, which is useful for the improvement of phospholipid, lipid biochemical studies and the like, and a method capable of producing DHA-rich phospholipid and lysophospholipi...
|
|
WO/2006/113475A2 |
Methods and compositions are provided which improve the adhesion of a bacteria to target substrates and/or improve the stress tolerance of a bacteria. Methods comprise exposing bacteria to adhesion adaptive conditions and thereby increas...
|
|
WO/2006/085672A2 |
A method for isolating one compound or more than one compound from a biomass which contains microorganisms that have produced the compound or compounds, the method comprising the following steps: (a) preparing or obtaining wet cells havi...
|
|
WO/2006/045916A2 |
The invention relates to a method of preparing a monomer, an oligomer, a polymer or a copolymer of an organosiloxane or a functionalised silane (A), comprising the following steps consisting in: a) reacting at least one monomer, oligomer...
|
|
WO/2006/015773A2 |
Disclosed is a method for enzymatically producing and/or modifying phosphatides, in which the head group is replaced with the aid of phospholipase D (PLD) obtained from Streptoverticillium flavopersicum, Streptoverticillium netropsis, an...
|
|
WO/2005/113759A2 |
The invention provides methods and compositions for production of xylitol, xylose, or combinations thereof from simple sugars from biosynthetic pathway that utilize D-fructose-6-phosphate and D-xylulose-5-phosphate as pathway intermediates.
|
|
WO/2005/111206A1 |
The present invention provides an M-1-P-producing enzyme which employs, as starting materials, an oligosaccharide or polysaccharide having a glucose polymerization degree of 5 or more and containing an &agr -1,4-glycosidic bond such as m...
|
|
WO/2005/106004A1 |
The invention relates to a method for producing bioactive surfaces by enzymatic modification of molecules or molecular aggregates, in particular, collagen, on surfaces of glass, metals, metallic oxides, plastics, biopolymers or other mat...
|
|
WO/2005/100579A1 |
Processes for enzymatic modification of lecithin and related materials, and hydrolyzed products obtained by such modification, are disclosed. One particular implementation provides methods for producing a hydrolysed product containing hy...
|
|
WO/2005/090587A1 |
It is intended to provide a method of removing an enzyme from a liquid enzymatic reaction mixture employed in a hydrolysis reaction or a base exchange reaction of a phospholipid. This method comprises the step of treating the liquid enzy...
|
|
WO/2005/087939A1 |
The method for effecting the biological decomposition of a substance containing a silicon carbon single bond is characterized in that a mixture consisting of the substance and of a microorganism population is incubated under anaerobic or...
|
|
WO/2005/085459A1 |
Methods of forming organic molecules comprising contacting a hydrolase enzyme with an organic reactant are provided. Methods for forming an organosilicon molecule comprising contacting cutinase with an organosilicon reactant are also pro...
|
|
WO/2005/083101A1 |
It is intended to provide a process for efficiently and stably producing an LCPUFA-PL. More specifically speaking, a process for producing a phospholipid which is a phospholipid containing a long chain polyunsaturated fatty acid (LCPUFA)...
|
|
WO/2005/073387A2 |
The invention relates to a method for obtaining the molybdopterin derivative precursor Z, whereby an over-production of precursor Z occurs in host organisms by recombinant expression of precursor Z synthesizing proteins. The invention fu...
|
|
WO/2005/068644A1 |
The invention relates to a method for the production of phosphatidylserine from a phospholipid (mixture) and serine in an aqueous system by transphosphatidylation in the presence of a protein with phospholipase D (PLD) activity and in th...
|
|
WO/2005/040076A1 |
Process for the preparation of an alkynol with formula HC=C-C(OH)-R2 (formula 2) wherein R2 represents methyl, halomethyl or ethyl, wherein the corresponding silyl-protected alkynol ester with formula 1 (1) wherein R1 represents H, or an...
|
|
WO/2005/038037A2 |
Methods for the production of omega-3 and/or omega-6 enriched glycerophospholipids are provided, which are based on enzymatic transesterification and esterification through phospholipases PLA1 and PLA2, chemical synthesis, and enzymatic ...
|
|
WO/2005/030949A1 |
Novel enzymes and novel enzymatic pathways for the pyruvate-based synthesis of shikimate or at least one intermediate thereto or derivative thereof, nucleic acids encoding the enzymes, cells transformed therewith, and kits containing sai...
|
|
WO/2004/089295A2 |
Novel chemistries, methods and assays are described for the rapid detection and measurement of phosphorylation or de-phosphorylation of polypeptides, oligonucleotides or lipids based upon the use of phosphoryl, phosphoroamino or phosphor...
|
|
WO2003031593A9 |
Methods for hydrolyzing solid ungranulated lysophosphatidylcholine with phospholipase A2 are provided. Also disclosed are methods for making a lipid matrix of lysophosphatidylcholine, monoglyceride and fatty acid, and lipid matrices of p...
|
|
WO/2004/050095A1 |
The present invention concerns a previously known chemical entity, fluopsin C, and its use as an agent for the treatment of cancer and bacterial and fungal infections as well as two novel bacterial isolates of Pseudomonas sp., which prod...
|
|
WO/2004/024907A1 |
The invention relates to a novel protein fraction with phospholipase D activity. Said fraction originates from members of the Papaveraceae family, in particular Papaver somniferum and is composed of two protein sub-fractions A and B, who...
|
|
WO/2004/016625A2 |
Methods for forming organosilicon esters and amides are provided. Additionally, organosilicon esters and amides are provided. The organosilicon esters and amides may be formed by contacting a hydrolase enzyme with an organosilicon reacta...
|
|
WO/2003/103625A2 |
The invention relates to method and compositions based on unsaturated metabolic phospholipids for the treatments of wrinkles and striae distensae. Said phospholipids were found to be useful to manufacture effective anti-wrinkle topical c...
|
